University of Connecticut;Joslin Diabetes Center, Inc,
发明人:
LYNES, Michael A.,TSENG, Yu-Hua,LYNES, Matthew D.
申请号：
AU2019209491
公开号：
AU2019209491A1
申请日:
2019.01.17
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Disclosed herein are uses of inhibitor of extracellular human metallothionein (MT) to treat a disorder selected from the group consisting of diabetes, pre-diabetes, impaired glucose tolerance, hepatitis, and/or inflammatory liver disease, and compositions containing extracellular human MT.
